C-EOHUGero
physics-informed AI, aging biology, therapeutics
discoverydiscoveringbiologic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-EOHU
C-EOHUC-EOHUphysics-informed AI, aging biology, therapeutics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Discover how gerophysics and longevity AI are changing the future of human healthspan and age reversal research. In this interview, Dr. Peter Fedichev, CEO of Gero, breaks down how complex systems science and generative AI are being used to map the biological limits of aging and discover new anti-aging therapeutics. Some links are affiliate links so we will earn a commission when they are used to purchase products. 🧬 SUPPORT THE CHANNEL & LONGEVITY PARTNERS If you would like to support our channel please consider joining our Patreon https://patreon.com/ModernHealthspan ~~~~~~~~~~~~~~ *Qualia* (15% off: MODERN) Creatine+ https://tinyurl.com/mr3z35jd Senolytic https://bit.ly/4jlaibe *Renue By Science* (10% off: MHS) https://tinyurl.com/bdew4bfs NMN Powder • Lipo NR *BiOptimizers* (15% off: MHBIO) https://bit.ly/47VAa8f - Magnesium Breakthrough, Gluten Guardian *Seeking Health* (10% off: Richard10) https://crrnt.app/SEEK/-dm0MyrQ, Histamine Nutrients https://crrnt.app/SEEK/EpM7paAO
In this episode , I speak with Peter Fedichev, co-founder and CEO of Gero, about whether aging can be understood through just three variables: stress, damage, and noise. He explains why many current longevity interventions may only be “level 1” therapies, why mice and humans may age in fundamentally different ways, and what it could take to push human lifespan beyond its current apparent limit. Find me on Twitter - https://twitter.com/EleanorSheekey official website - https://www.thesheekeyscienceshow.com/ Support the channel through PayPal - https://paypal.me/sheekeyscience?country.x=GB&locale.x=en_GB through Patreon - https://www.patreon.com/TheSheekeyScienceShow 0:00 – Aging as a 3-variable system: why aging may be better understood through a minimal model rather than a huge list of hallmarks. 12:58 – Stress, damage, and noise: the three factors Peter says shape aging trajectories. 22:36 – Why mice and humans age differently: stable vs unstable species. 34:36 – Can damaged ti
During MedTech World Middle East | Dubai 2026, Peter Fedichev, Co-founder and CEO of GERO, discusses how artificial intelligence and biotechnology are coming together to unlock new possibilities in longevity science. GERO is using AI to analyse massive volumes of clinical and genetic data to identify new therapeutic targets. According to Fedichev, the next major breakthrough in biotechnology could be drugs that address aging itself, rather than treating diseases one by one. He also highlights how demographic shifts, particularly in parts of Asia such as Japan, China, and Singapore, are increasing the urgency to develop therapies that support healthier aging populations. Fedichev explains why regions that support research, data access, and regulatory progress in longevity science could play a major role in the future of drug development. Events like MedTech World provide a valuable platform to connect innovators, investors, and policymakers working toward the next generation of health
Can aging be reversed — or just slowed? David Sinclair says aging is like a software glitch that can be fully restored. Peter Fedichev, physicist and CEO of Gero, disagrees — and has the math to prove it. In this clip from the Gero/JPM Healthcare event, Fedichev explains: → Why aging has TWO distinct components → Which part CAN be reversed (and by how much) → Which part is thermodynamically irreversible → Why the 2nd law of thermodynamics sets a hard limit on rejuvenation The answer changes everything about how we should approach longevity research and drug development. See the details and more insights in the full video: https://www.youtube.com/watch?v=k1N2iqK78W0 Follow Peter on X: https://x.com/fedichev #aging #longevity #davidSinclair #geroscience #biology #physics #antiaging #healthspan
At MedTech World Middle East 2026, the panel “From Data to Decisions: The New Era of Precision Diagnostics & Therapy” explored how healthcare systems can turn complex data into real-world clinical action. Moderated by Simon Swift, Commercial Director at Healthcare World, the discussion brought together leaders from across the ecosystem: Alex Diaconu, CEO & Co-Founder of AiGIA Dr. Ramzy Ross, Director Shared Clinical Services at Mediclinic Middle East Rachna Dayal, Managing Partner at Sugati Ventures Abhishek Shah, President of TruDoc Maxim Kholin, Co-Founder of Gero From data liquidity and interoperability challenges to AI agents, multiomics, longevity science, reimbursement realities, and last-mile execution, the conversation moved beyond theory. Panelists debated how to: • Break down silos and enable governed, patient-driven data access • Translate precision diagnostics into actionable care pathways • Align incentives between providers, payers, patients, and inves
Presented at Gero's side event during the JP Morgan Healthcare Conference (January 2026), this talk explores how we're applying theoretical physics and AI to develop transformational—not incremental—solutions against aging. time codes: 0:01 – Gero introduction by Laurence Ion (VitaDAO) 0:25 – Peter Fedichev presentation 24:47 – How to advance U.S.-based drug and peptide manufacturing 26:08 – The role of quantum physics in biology 28:50 – The role of dog experiments and what we should do about aging today 31:04 – What is the best strategy for designing clinical trials against aging? 34:40 – The difference between physics and biology from a research and AI perspective 38:19 – Is there a reversible component in aging? 41:21 – What is the current research on the hallmarks of aging, and how do researchers get funding for it? 45:34 – What will a product that stops aging look like, and what will happen when organs become swappable? 47:34 – Why is aging not reversible whil
Maxim Kholin, Gero, presents at the 12th Aging Research and Drug Discovery meeting: Engineering the Path to Radical Life Extension
In this Media Lounge interview recorded live at MedTech Malta 2025 in Valletta, Malta, Maxim Kholin, Co-founder of Gero, joins MedTech World to explore one of the most ambitious frontiers in healthcare: the science of aging. Maxim explains how Gero applies physics and big data to model human biology and aging, drawing insights from non-aging species such as naked mole rats, bats, turtles, and sharks. He discusses why aging may not be a fixed law of nature, Gero’s collaborations with major pharmaceutical companies, and why longevity science is attracting attention from non-traditional investors shaping the future of healthcare. 🎙️ Hosted by MedTech World 📍 Recorded live in Valletta, Malta 🤝 MedTech Malta 2025 | Mediterranean Conference Centre Subscribe for more interviews, event coverage, and expert conversations from the global MedTech community. Learn more: https://med-tech.world/
Peter Fedichev, Gero, presents at the 12th Aging Research and Drug Discovery meeting: Aging from the Second Law: Entropic Damage, Effective Temperature, and Extreme-Statistics Control of Lifespan
Our conversation with Dr. Peter Fedichev, CEO of Gero AI, explores the scientific understanding of aging as an entropic process. He argues that radical lifespan extension is achievable, and we discuss how complex this might be.
Humans have been known to live up to 120 years. But why stop there? And why don't more of us reach that age? In this episode we discuss radical human lifespan extension, and the science of human aging, with theoretical physicist and geroscience pioneer, Dr. Peter Fedichev, an active research scientist and CEO of GERO AI. You may find Dr. Fedichev on X: https://x.com/fedichev And on Youtube: https://www.youtube.com/@fedichev Subscribe to Saving Sapiens Podcast for future episodes!
Every innovator must answer: how will you get paid? Moderated by Karandeep Singh Badwal (QRA Medical), this essential panel features Lee Fleisher (Rubrum Advising, Former CMO-Centers for Medicare & Medicaid Services), Limor Sandach (Pregnan Tech, NeoFlow & Almeda Ventures), Chad Bonhomme (Grand Heart), and Maxim Kholin (Gero). Explore reimbursement, direct-to-consumer, employer partnerships, and hybrid revenue models designed from day one. 🎙️ Hosted by MedTech World 📍 Recorded live in Valletta, Malta 🤝 MedTech Malta 2025 - Day 1 at the Mediterranean Conference Centre Subscribe for more interviews, event coverage, and expert conversations from the global MedTech community. Learn more: https://med-tech.world/
Anti-aging research reaches critical breakthrough moment in 2025 as AI-powered drug discovery moves from promise to proof, with longevity companies like Gero applying physics to model biology and potentially stop human aging. In this fascinating myth-busting interview from MedTech World Singapore 2025, discover how naked mole rats, AI prediction models, and revolutionary approaches to aging could transform human healthspan. Maxim Kholin from Gero sheds light on the truth behind common longevity myths: from AI's revolutionary impact on drug discovery using 100 million electronic medical records, to why healthy longevity isn't just about living longer but staying young and healthy like naked mole rats, and why anti-aging innovations won't be exclusive to billionaires but could become as accessible as COVID vaccines. #medtechworld #antiaging #aihealthtech
This talk was presented at Longevity Global's 4th Annual Longevity Summit on Dec 5-6, 2024. Sign up for Longevity Global's 5th Annual Longevity Summit on Dec 9-10, 2025 at the Buck Institute in Novato, CA: https://lu.ma/zlfezwd3 https://longevitygl.org/longevity-summit/
Aging is more than disease—it’s the steady decline of function. In this episode of Longevity by Design, Dr. Gil Blander speaks with physicist-turned-biotech innovator Dr. Peter Fedichev about why resilience, not diseases, holds the key to longer lives. Peter explains how his background in theoretical physics shaped his approach to biology and aging. He outlines why startups, not large institutions, are now leading innovation in longevity science. Drawing from physics, he describes aging as a series of “jumps” between states, each leaving the body more fragile. The discussion moves from the limits of current drugs to the promise of new approaches. Peter argues that reducing fluctuations and increasing molecular fidelity could unlock far greater gains in healthspan and lifespan. Listeners gain a fresh lens on what drives aging, where the real breakthroughs may come from, and why the next frontier in longevity will require rethinking the problem altogether. Guest-at-a-Glance
👉 Join the Hackathon: https://forimmortality.ai The latest results from launching a new series of hackathons at the intersection of life extension, multi-agent systems, and artificial intelligence. We discuss how the first event went, what tasks participants tackled, what the “healthy longevity” philosophy leads to, where real progress is happening, and where the traps of the popular “Healthspan vs Lifespan” narrative lie. ———————————————————————————— 👥 Participants: — Petr Fedichev @fedichev (Gero) https://x.com/fedichev — Vita Stepanova @blastim https://t.me/blastim — Misha Batin https://x.com/MikhailBatin ———————————————————————————— ⏳ Timestamps: 00:00:00 - Introduction: Race for Immortality 00:00:34 - The era of longevity revolution (2025, hackathons) 00:00:53 - Integrating AI into the fight against aging 00:01:21 - Vita on the hackathon and multi-agent systems 00:05:43 - Task experiments (strict vs open-ended) 00:06:49 - Open tasks for generating new ideas 00:07:40 - Succ
We’ve been looking at aging the wrong way. What if it’s not just a cellular process, but a thermodynamic one? 🔬⚙️ This changes everything. 🎙New episode of Decoding Longevity out now. Featuring physicist & Gero founder Peter Fedichev 👇 Listen now & rethink aging. #LongevityScience #DecodingLongevity #AgingReversal #PeterFedichev #BiotechReels #Healthspan #Gero #FutureOfAging #Thermodynamics #AgingIsNotInevitable
This episode's guest is Peter Fedichev - a physicist-turned-biotech visionary who is applying the principles of physics to geroscience. As the founder and CEO of Gero, Peter is at the forefront of longevity science, blending cutting-edge AI with deep biological insight to crack the code of aging itself. From his early days in theoretical physics to launching one of the most innovative health tech companies in the world, Peter is one of the most notable persons within the longevity field. Buckle up — we’re diving into the future of human lifespan with one of its boldest architects. Support us by subscribing and hitting the notification bell. We have some amazing interviews coming up! 🚀 Special offer for our LEVITY audience: Join Vitalism today and receive a 30% discount on your membership using the code LEVITY at checkout. https://www.vitalism.io/membership 🚀 Show notes for this episode is available here: https://reachlevity.com/p/age-reversal-will-never-work-a-controversial-take-f
Gero: Ask Me Anything Session at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io. Speaker: Peter Fedichev Co-Founder and CEO of Gero.ai https://gero.ai/ FOLLOW US ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ https://www.lifespan.io https://twitter.com/lifespanio https://www.facebook.com/lifespanio https://www.instagram.com/lifespan.io HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: https://www.lifespan.io/support ► Subscribe: https://www.youtube.com/user/LifespanIO?sub_confirmation=1 ► Learn more, and help us: https://www.lifespan.io #longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenation
🚀 Welcome to Maxim Kholin’s presentation on "Gero: Ending Aging and Age-Related Diseases." Maxim Kholin is the Co-founder of Gero, a pioneering longevity biotech company, and Quantum Pharmaceuticals, a drug discovery company specializing in molecular modeling. In this session, Maxim explores how Gero is advancing the fight against aging and age-related diseases through innovative biotech solutions. Maxim plays a key role in business development and strategic partnerships at Gero, where the ultimate mission is to conquer aging and make anti-aging therapies widely available. Join us for an insightful discussion on the future of longevity and the groundbreaking technologies that are shaping this field. 🔗 Connect with Maxim Kholin on LinkedIn: https://www.linkedin.com/in/maximkholin/ 🌐 Visit Gero: https://gero.ai/ 🔗 Follow Gero on LinkedIn: https://www.linkedin.com/company/gero/posts/?feedView=all
In this 1.5-hour episode of the podcast, we dive deep into the cutting-edge world of longevity research with Peter Fedichev, founder of Gero, and Aleksandr Sviridov. The conversation explores the intersection of physics, biology, and ageing, offering fascinating insights into the current state and future potential of longevity science. Key topics discussed include: The application of physics tools to understand aging and the importance of a phenomenological approach Distinguishing between reversible and irreversible aspects of ageing Challenges in biological data collection and the shift towards more quantitative approaches The potential of large public datasets and plasma proteomics in drug discoveryEstablishing a standard model of ageing and identifying variables related to maximum human lifespan The limitations of lifespan as a measure of ageing and the need for more comprehensive variables Potential interventions including pharmacological, cellular, and gene therapies Alternative
#youtubeshorts from @ProgressPotentialPossibilities @youtubecreators Dr. Peter Fedichev, PhD - CEO, Gero - Hacking Complex Diseases & Aging with AI & Digital Biomarkers https://www.youtube.com/watch?v=G5OH9zsfm6Y #PeterFedichev #Gero #Aging #AI #DigitalBiomarkers #Rejuvenation #Pfizer #AubreyDeGrey #Longevity #Physics #ProgressPotentialAndPossibilities #Innovation #Technology #Science #Research #youtubehighfive
Have you ever wondered if science could potentially double the human lifespan? That's the moonshot biotech company Gero is chasing. Led by physicist-turned-CEO and Co-Founder Peter Fedichev, Gero harnesses the mind-bending mix of physics, AI, and good old biology to develop therapeutics against chronic diseases and slow down human aging itself. They're not just throwing darts—Gero is developing mRNA vaccines, similar to those used for COVID-19, to fight aging. With partnerships with industry giants like Pfizer, Gero is on the cusp of revolutionizing longevity. Interested in living a longer, healthier life? This is your chance to be a part of something truly groundbreaking— visit Gero’s website today: https://gero.ai/ #AIcompany #BiotechStocks #Biotech #stockstobuynow #biology #physics #stocks #antiaging #stockstowatch #stockstotrade 00:00 Intro 00:43 Research in "Hacking Aging" and "Principles of Aging". 02:16 GERO Models Originate From The Physics of Complex Dynamic Systems. 04
Peter Fedichev, CEO Gero, Singapore presents at the 10th Aging Research and Drug Discovery conference: Aging clocks, entropy, and the limits of age-reversal.
6th Edition: AGING & GERONTOLOGY - Sciinov Group www.agingcongress.com Aging clocks, entropy, maximum human lifespan, and the challenge of age-reversal Peter Fedichev Gero LLC PTE, Singapore Title: Aging clocks, entropy, maximum human lifespan, and the challenge of age-reversal Sciinov Group is a specialized international events organizer, and provider of customized data intelligence databases, trends and insights that solve information challenges and caters organizations needs. Sciinov Conferences mission is to benefit attendees by networking their peers, often potential clients and learn from the high quality of information delivered by the expert speakers. Our expert teams deliver events and exhibitions, create intelligence-based products and data-driven services, congregate communities in person and digitally and provide access to cutting-edge research for clients working in specialist markets, globally.
Dr. Peter Fedichev, Ph.D. is the CEO of Gero (https://gero.ai/), a biotech company focused on hacking complex diseases, including aging, with AI for novel drug discovery, as well as digital biomarkers. Gero’s models originate from the physics of complex dynamic systems, combining the potential of deep neural networks with the physical models to study dynamical processes and understand what drives diseases. Dr. Fedichev has a background in biophysics, bioinformatics and condensed matter physics, earning his Ph.D. from the University of Amsterdam, and he conducted research at FOM Institute AMOLF (part of the institutes organization of the Dutch Research Council of Netherlands) and the University of Innsbruck. To date, Dr Fedichev has published over 70 papers covering his research on physics, biophysics and aging biology. #PeterFedichev #Gero #Aging #AI #DigitalBiomarkers #Longevity #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcas
Today I am joined by Dr. Peter Fedichev, founder of Gero, a longevity biotech company founded by a group of research scientists and entrepreneurs with the goal of creating a therapy that will extend human lifespan. Gero is a group of companies that develop biomarkers and new drugs to treat complex diseases. Gero is pioneering a drug discovery based on Whole Exome Sequencing data. Gero biomarkers and anti-aging targets discovery is based on analysis of big datasets of biomedical data. Peter obtained his Ph.D. from the University of Amsterdam. His research interest includes condensed matter physics, biophysics, bioinformatics. Petr has more than 40 scientific publications in peer-reviewed journals and many patents. Scott Amyx Innovation Keynote Speaker | Trend Spotter | Experiential, Interactive, Engaging www.scottamyx.com Energize, inspire & engage your audience. Book Scott Amyx today for valuable insights into the future of work, productivity & society. About Scott Amyx Scot
Peter Fedichev is Founder and Chief Science Officer at Gero. We discuss the current state of anti-aging and longevity research and what can we do now to prolong our lives. Support me on Patreon: https://patreon.com/gregmustreader My Twitter: https://twitter.com/mustreader My blog on Medium: https://medium.com/@mustreader My Instagram: https://instagram.com/mustreader Peter Fedichev: https://facebook.com/peter.fedichev Gero AI: https://gerosense.ai Audio version of the podcast: Apple Podcasts: https://apple.co/2O6Xd81 Google Podcasts: https://bit.ly/2O4mL5V Spotify: https://spoti.fi/2U0YOjs Deezer: https://bit.ly/36xoEhU Pocket Casts: https://pca.st/yxj7w02o Castbox: https://castbox.fm/va/2523108 My podcast with Aubrey De Grey: https://youtu.be/0GqqOtTryC4 My podcast with Brian Kennedy: https://youtu.be/BMgA5oKQx3Q Peter Fedichev at TEDxSkolkovoChange: https://youtu.be/EoJVdVpOLK0 0:00 – Intro 1:16 – Fighting aging 3:35 – Difference between aging and mortality 6:56 – Delaying aging
In this week's #HealthyLongevity webinar session, join us as we explore the use of big biomedical data in AI and machine learning to discover novel biomarkers of #ageing and therapeutics with Dr Peter Fedichev, CEO and Co-Founder of Gero. Register for the upcoming webinar sessions here: https://nus-sg.zoom.us/webinar/register/3016397215018/WN__sypkX6ZSomc7cGAkK3LbA #NUSMedicine #webinarseries --- Disclaimer: The opinions and advice expressed in this webinar are those of the speakers and do not represent the views and opinions of the organizers and National University of Singapore or any of its subsidiaries or affiliates. The information provided in this webinar is for general information purposes only as part of a general discussion on public health. The information is not intended to be a substitute for professional medical advice, diagnoses or treatment; and cannot be relied on in place of consultation with your licensed healthcare provider. All Rights Reserved. All
На онлайн-мероприятии участники обсудили реализацию биомедицинских проектов в сфере старения и долголетия и сложности и возможности которые принесла пандемия Covid-19. Исследователи, разработчики и активисты рассказали о своих проектах. Данный вебинар организован РОО "Совет по общественному здоровью и проблемам демографии", членом Международного альянса за продление жизни (International Longevity Alliance) под эгидой Национальной технологической инициативы (рынок HealthNet) в рамках традиционного октябрьского ралли в честь Международного для долголетия (Международного дня пожилого человека ООН). Спикеры: Дарья Халтурина (Daria Khaltourina) – Совет по общественному здоровью и проблемам демографии (Council for Public Health and the Problems of Demography) Алексей Москалев (Alexey Moskalev) – член корр. РАН, зав. лабораторией геропротекторных и радиопротектореых технологий Института биологии ФИЦ Коми НЦ УрО РАН Илья Стамблер (Ilia Stambler) – Ассоциация «Ветек» - Движение за долголет
Dr Peter Fedichev, Founder of Gero speaking at Master Investor’s Investing in the Age of Longevity 2019 event. Master Investor is an investment media and events company that delivers independent, financial commentary and analysis to UK private investors and traders through events, magazines, news, blogs, podcasts and daily/weekly newsletters. Read our latest magazine at www.masterinvestor.co.uk/magazine Book a free ticket (use code MIYT) to attend the annual Master Investor Show (28th March 2020): https://masterinvestorshow-2020.reg.buzz Keep in touch: Newsletter | https://masterinvestor.co.uk/subscribe Twitter | https://twitter.com/masterinvestor Facebook | https://facebook.com/masterinvestor LinkedIn | https://www.linkedin.com/company/masterinvestor
Gero is a data-driven longevity company that employs physics to reverse engineer biology. Gero's goal is to extend healthy lifespan and delay the onset of chronic age-related diseases. Peter Fedichev, PhD is Founder & Chief Science Officer of Gero. A passionate scientist with a background in biophysics, bioinformatics and condensed matter physics, Peter is the driving force behind our team. He earned his Ph.D. from the University of Amsterdam and conducted research at FOM Institute AMOLF (Netherlands) and the University of Innsbruck. To date, he has published over 70 papers covering his research on physics, biophysics and aging biology. Many thanks for watching! Consider supporting SciFuture by: a) Subscribing to the SciFuture YouTube channel: http://youtube.com/subscription_center?add_user=TheRationalFuture b) Donating - Bitcoin: 1BxusYmpynJsH4i8681aBuw9ZTxbKoUi22 - Etherium: 0xd46a6e88c4fe179d04464caf42626d0c9cab1c6b - Patreon: https://www.patreon.com/scifuture c) Sharing
The main goal is to establish echocardiographic reference values of the right heart for pregnant women, assuming they differ significantly from those of non pregnant women of same age. Therefore the investigators will use existing reference values published by American society of echocardiography and European Association of Echocardiography. As side arms the investigators want to explore, whether illness of either fetus or mother is connected with right heart affection.
The best opening in a physics textbook (Peter Fedichev from gero.ai). 22. 19 ...
3y ago. The best opening in a physics textbook (Peter Fedichev from gero.ai). 22. 19. CMV: The Bolsheviks bastardized communism which became ...
The best opening in a physics textbook (Peter Fedichev from gero.ai) ... The best opening in a physics textbook (Peter Fedichev from gero.ai).
The best opening in a physics textbook (Peter Fedichev from gero.ai). 22. 19. Einstein is the unambiguous standard scientist. Who's a ...
Thoughts on Peter Fedichev's Research and Conclusions on Aging. ... He also has a personal website Gero.ai, I think he has some more technical ...
The best opening in a physics textbook (Peter Fedichev from gero.ai). 22. 19. What are the list of pseudoscience subjects in quantum mechanics ...
Peter Fedichev, co-founder of GERO, discussed biomarkers in the context of mouse research, particularly physiological frailty and blood cell ...
Peter Fedichev on enthropic aging and possibilities of life extension ... Level-2 drugs are longevity 2.0, and they are our focus in Gero.
... Peter Fedichev, CEO and Co-Founder of Gero. More posts ... Building a virtual model to solve human aging - Peter Fedichev explains how Gero ...
Building a virtual model to solve human aging - Peter Fedichev explains how Gero is using AI and activity data to accelerate our understanding ...
The best opening in a physics textbook (Peter Fedichev from gero.ai). Hayflick noted that aging is not just a biological problem but also a ...
Peter Fedichev, PhD is Founder & Chief Science Officer at Gero A passionate scientist with a background in biophysics, bioinformatics and ...
3y ago. The best opening in a physics textbook (Peter Fedichev from gero.ai). 22. 19. The Geographic Mosaic Theory of Coevolution · r ...
Peter Fedichev is making it measurable—and reversible. At Gero, he's pioneering digital biomarkers and drug discovery to tackle complex ...
Peter Fedichev ... Ph.D. from the University of Amsterdam. Co-founder of Gero, a data-drivenlongevitybiotech company, that develops new drugs against aging and ...
Join us for this insightful episode with Dr Peter Fedichev, CEO and Co-founder of Gero ... presented, including common-law copyright, are ...
Peter Fedichev, CEO of Gero.ai, one of the thought leaders in longevity and another proponent of radical biotech solutions to the aging problem, who applies ...
... Maxim Kholin, Co-Founder & Head of Corporate Affairs, Gero Event photos are now available on Flickr, you might be in one of the captured ...
MAXIM KHOLIN is Co-founder of Gero (Singapore), being responsible for business development and legal affairs. Gero is an AI driven drug discovery company.
Maxim Kholin. Co-Founder, Gero. Max Kholin is Co-Founder of GERO, a biotechnology company applying AI and physics-based generative models to drug discovery in ...
The American Society of Clinical Oncology (ASCO) has played a key role in ... gero-oncology education and facilitating gero-oncology nursing research.
... gero-oncology nursing research and established updated research ... ASCO.org.
ASCO ... Presentation Details. First Author. Gero Kramer. Presenter. Gero Kramer ... © 2026 American Society of Clinical Oncology (ASCO). All Rights Reserved ...
Gero is a cutting-edge biotechnology company dedicated to the ... From AACR poster to Clinical Leader byline (+ podcast): Etira's biotech PR playbook.
In: Proceedings of the AACR Special Conference in Cancer Research ... Published by American Association for Cancer Research. Journal of Pharmacology and ...
Gero Secures $6M in Series A Extension Round to Advance AI-Based Age ... AACR 2026: Breakthroughs and Setbacks in Oncology Pipelines. April 21, 2026 ...
Thomas Gero. 1Dana-Farber Cancer Institute, Boston, MA,. Search for ... In: Proceedings of the AACR Special Conference in Cancer Research ...
The Gerontological Society of America (GSA) — the nation's largest ... GERO-BC, PHNA-BC, CNE, FGSA, Florida Atlantic University ...
Gero Research. Our Research. As an initiative dedicated to gerontology, we ... The Gerontological Society of America (GSA) is the largest and most ...
Kickoff of the GBHI-AAIC Satellite Symposium in Lima, Peru ... Kickoff of the GBHI-AAIC Satellite ... GERO Trinity College Dublin · No photo description ...
AAIC 2025 International Conference ... Geroscience Center for Brain Health and Metabolism (GERO); Neurology Unit, Hospital San José; Universidad de Chile ... Art at ...
GERO Researchers Participate in the Alzheimer's Association International Conference (AAIC) 2024. From July 28 to August 1, 2024, several ...
2006 Gordon Research Conference, Aging, Biology Of 2006年 ポスター発表 ... Gero...詳細. ×. Oxidative stress activates the forkhead transcription factor ...
Peter Fedichev of Gero presented on the company's use of AI and animal models to characterize the split of degenerative aging into two quite ...
Peter Fedichev CEO of Gero, introduces Gero's approach on how to make pharma stop worrying and love aging - New video from Rejuvenation Startup ...
Peter Fedichev, CEO of Gero at Rejuvenation Startup Summit 2022 Connect to Forever Healthy: * Videos: https://forever-healthy.org/videos/ ...
Microsoft is a proud sponsor of the AHLI Machine Learning for Health ... Gero; Cliff Wong; Rajesh Jena; Eric Horvitz; Amanda K. Hall, Rachel Ruican ...
Proceedings of the Fifth Machine Learning for Health ... Volume 297: Machine Learning for Health Symposium ... Gero, Cliff Wong, Rajesh Jena, Eric Horvitz, Amanda K ...
4th Machine Learning for Health symposium - ML4H 2024. Collection of ... Zelalem Gero, Chandan Singh, Yiqing Xie, Sheng Zhang, Praveen ...
Microsoft is a proud sponsor of the AHLI Machine Learning for Health ... Zelalem Gero; Chandan Singh; Yiqing Xie; Sheng Zhang; Praveen ...
As I was landing in San Francisco to attend the JP Morgan Healthcare conference ... Gero. 1y. Report this comment; Close menu.. Like · Reply · 1 ...
... Gero @hacking_aging Thank you, @strygah @longevion @ ... This week, during J.P. Morgan Healthcare Conference week, we ...
2020 JP Morgan Healthcare Conference logo and presentations ... Gero), pharma (Novartis) and policy (GHPI and Health Systems Reform) ...
Peter Fedichev, Co-founder and CEO of Gero, has been named among Rising Stars in Longevity by Business Insider ... BIO International Convention ...
Kristina Zakurdaeva, Gero Chief Medical Officer, shares Gero experience at the BIO International Convention 2019 #BIO2019 #hackingaging.
Gero LLC, a leading drug development company, arranged a session at the Bio International Convention 2016 held at San Francisco from 6th-9th June.
... Gero), pharma (Novartis) and policy (GHPI and ... BIO International Convention was crowded with biopharma firms from the country looking for partnerships. ... BIO ...
Vitalist Bay: A new beacon for longevity innovation and collaboration ... (Gero CEO) and others, including myself, alongside experts from ...
Vitalist Bay, world's largest longevity event combines longevity ... Gero). These individuals, alongside others from academia, industry ...
Excited to be speaking today at the Longevity Investors Conference. I'll be presenting at 18:20 on how Gero is redefining drug discovery at the frontier of ...
Longevity Investors Conference. 6d. . The companies that have stood in front of our investors at LIC are still making waves. 🏔️ GERO.
Sep 7th-10th, 2023 RAAD Fest https://raadfest.com Anaheim, CA (1h ... Gero), pharma (Novartis) and policy (GHPI and Health Systems ...
Sep 7th-10th, 2023 RAAD Fest https://raadfest.com Anaheim, CA (1h ... Gero), pharma (Novartis) and policy (GHPI and Health Systems ...
... RAADfest 2026 continues that commitment. Because extending ... GERO BIOAGE TruDiagnostic DeepOrigin &molecule ONE SKIN REJUVE.BIO ...
Aging Research and Drug Discovery Meeting (ARDD) today at 5:40 pm. At Gero, our mission is to radically extend healthy lifespan and fight multiple age ...
This year's 8th Annual Aging Research and Drug Discovery (ARDD) meeting was ... gero-therapeutic target. He showed that combined genetic and ...
ARDD Meeting (@ARDD_Meeting). 268 views. This ARDD ... Maxim Kholin, Gero, presents at the 12th Aging Research and Drug Discovery meeting: ...
Gero is a therapeutics company targeting the root physics of aging to add decades — not just years — of healthy life ...
Peter Fedichev ... Peter was top-2 cited Russian physicist under 35 before he switched to biotech 15 years ago. In 2015, he co-founded Gero, AI-driven longevity ...
Peter Fedichev. founder, Gero. Verified email at gero.com - Homepage · A physicist in drug discovery land: agingdrug designcondensed matter ...
Peter Fedichev, GERO, University of Amsterdam, About, I am a scientist and entrepreneur with over 20 years of experience in academic research.
Peter Fedichev ; Scientific career ; Physicist, biotechnologist, entrepreneur · Research on quantitative models of ageing; co-founding Gero.ai. Scientific career.
www.gero.ai · Artificial Intelligence (AI) · Biotechnology · Genetics · Pharmaceutical ... Photo of Maxim Kholin. Maxim Kholin: Co-founder, Head of Corporate ...
Maxim Kholin, Peter Fedichev. Year Founded. 2012. Number of employees. 50 ... gero.ai/publications. Categories. AI / Machine Learning · Drugs · Small Molecules ...